Bit Capital Gmb H Cytokinetics Inc Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
A detailed history of Bit Capital Gmb H transactions in Cytokinetics Inc stock. As of the latest transaction made, Bit Capital Gmb H holds 19,283 shares of CYTK stock, worth $801,401. This represents 0.07% of its overall portfolio holdings.
Number of Shares
19,283Holding current value
$801,401% of portfolio
0.07%Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
409Shares Held
125MCall Options Held
4.55MPut Options Held
2.42M-
Black Rock Inc. New York, NY14.7MShares$610 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$495 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$403 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$328 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$268 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.91B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...